Open trial of Bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus-Reference-Cited by-同舟云学术

Open trial of Bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus

Published:2020-08-17 Issue:5 Volume:31 Page:410
ISSN:0959-4493
Container-title:Veterinary Dermatology
language:en
Short-container-title:Vet Dermatol

Author:

Goodale Elizabeth C.¹^ORCID,White Stephen D.¹^ORCID,Bizikova Petra²^ORCID,Borjesson Dori³,Murrell Dedee F.⁴^ORCID,Bisconte Angelina⁵,Francesco Michelle⁵,Hill Ronald J.⁵,Masjedizadeh Mohammad⁵,Nunn Philip⁵,Gourlay Steven G.⁵,Jordan Tyler J.M.¹,Emery Carolyn B.⁶,Outerbridge Catherine A.¹^ORCID

Affiliation:

1. Department of Medicine and Epidemiology School of Veterinary Medicine University of California Davis CA 95616 USA

2. Department of Clinical Sciences College of Veterinary Medicine NC State University 1060 William Moore Drive Raleigh NC 27607 USA

3. Departments of Pathology, Microbiology and Immunology School of Veterinary Medicine University of California Davis CA 95616 USA

4. Department of Dermatology St George Hospital University of New South Wales Sydney NSW 2217 Australia

5. Principia Biopharma Inc. 400 E Jamie Ct South San Francisco CA 94080 USA

6. William R. Pritchard Veterinary Medical Teaching Hospital School of Veterinary Medicine University of California Davis CA 95616 USA

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vde.12878

Reference12 articles.

1. Cloning and establishment of canine desmocollin-1 as a major autoantigen in canine pemphigus foliaceus

2. Desmoglein-1 is a minor autoantigen in dogs with pemphigus foliaceus

3. Oral glucocorticoid pulse therapy for induction of treatment of canine pemphigus foliaceus - a comparative study

4. The role of Bruton’s tyrosine kinase in autoimmunity and implications for therapy

5. A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of Bruton’s tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease;Expert Opinion on Pharmacotherapy;2024-08-12

2. Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study;Journal of Investigative Dermatology;2024-08

3. Bruton’s Tyrosine Kinase Inhibition in Pemphigus: An Embattled Frontier;Journal of Investigative Dermatology;2024-08

4. Pharmacology of drugs used in autoimmune dermatopathies in cats and dogs: A narrative review;Veterinary Dermatology;2024-05-06

5. Efficacy and safety of Bruton's tyrosine kinase inhibitors in the treatment of pemphigus: A comprehensive literature review and future perspective;Heliyon;2023-12